-
Travere Therapeutics' (TVTX) "Outperform" Rating Reaffirmed at Leerink Partners
Source: Buzz FX / 08 Oct 2024 09:11:10 America/Chicago
Travere Therapeutics' (TVTX) "Outperform" Rating Reaffirmed at Leerink Partners Written by MarketBeat October 8, 2024 Share Link copied to clipboard. Travere Therapeutics ( NASDAQ:TVTX - Get Free Report ) 's stock had its "outperform" ratin
Read more...